Pfizer-BioNTech vaccine deliveries could start 'before Christmas'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Wells Fargo Reiterates Overweight Rating on Johnson & Johnson (JNJ)
November 19, 2020 6:46 AM ESTWells Fargo analyst Larry Biegelsen reiterated an Overweight rating and $172.00 price target on Johnson & Johnson (NYSE: JNJ) following the company's virtual booth tour, ahead of its analyst day.
On its Q3 call, JNJ indicated that it expected Q4 MD recovery to continue with... More
Pfizer (PFE), BioNTech (BNTX) Confirm Phase 3 Study of COVID-19 Vaccine Candidate Shows 95% Efficacy
November 18, 2020 7:00 AM ESTPfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all of the studys primary efficacy endpoints. Analysis of the data indicates a vaccine efficacy rate of 95% (p... More



